Divi’s Laboratories Q1 FY27 Results: Net Profit Soars 65%, Revenue Crosses ₹3,000 Crore as EBITDA Margin Jumps Above 40%
Hyderabad: Divi’s Laboratories Ltd., one of India’s leading pharmaceutical and active pharmaceutical ingredient (API) manufacturers, delivered an outstanding performance in the first quarter of FY27. The company reported robust double-digit growth in revenue, operating profit, and net profit, with EBITDA margin expanding sharply compared to the same period last year. …